1503 related articles for article (PubMed ID: 1972141)
1. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T lymphocyte clones isolated from BCNU-cured LSA mice.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cell Cloning; 1991 Nov; 9(6):594-605. PubMed ID: 1770232
[TBL] [Abstract][Full Text] [Related]
3. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore.
Kakkanaiah VN; Nagarkatti PS; Nagarkatti M
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
Nagarkatti M; Clary SR; Nagarkatti PS
J Immunol; 1990 Jun; 144(12):4898-905. PubMed ID: 1972170
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties.
Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
Cell Immunol; 1990 May; 127(2):442-57. PubMed ID: 2139366
[TBL] [Abstract][Full Text] [Related]
6. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of mice bearing syngeneic tumors with 1,3-bis (2-chloroethyl)-1-nitrosourea is effective only in normal, but not in irradiated or nude, mice: role of L3T4+ (CD4+) and Lyt-2+ (CD8+) T cells.
Nagarkatti M; Seth A; Nagarkatti PS
Cell Immunol; 1988 Sep; 115(2):383-92. PubMed ID: 3261638
[TBL] [Abstract][Full Text] [Related]
8. High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1).
Maraskovsky E; Pech MH; Kelso A
Int Immunol; 1991 Mar; 3(3):255-64. PubMed ID: 1675587
[TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
Sad S; Mosmann TR
J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
[TBL] [Abstract][Full Text] [Related]
10. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
11. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
12. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
Klarnet JP; Kern DE; Dower SK; Matis LA; Cheever MA; Greenberg PD
J Immunol; 1989 Apr; 142(7):2187-91. PubMed ID: 2466890
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
Nagarkatti M; Toney DM; Nagarkatti PS
Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
[TBL] [Abstract][Full Text] [Related]
14. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
Suda T; Murray R; Guidos C; Zlotnik A
J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific suppression of antibody responses by T lymphocytes cytotoxic for antigen-presenting cells.
Kagaya K; Shang H; Miyakawa Y; Fukazawa Y
APMIS; 1994 Jun; 102(6):439-45. PubMed ID: 7520709
[TBL] [Abstract][Full Text] [Related]
16. Use of interleukin-7, interleukin-2, and interferon-gamma to propagate CD4+ T cells in culture with maintained antigen specificity.
Cohen PA; Kim H; Fowler DH; Gress RE; Jakobsen MK; Alexander RB; Mulé JJ; Carter C; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):242-52. PubMed ID: 7507711
[TBL] [Abstract][Full Text] [Related]
17. Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: role of IL-1 and IL-6 in inducing IL-2 secretion and subsequent proliferation.
Stein PH; Singer A
Int Immunol; 1992 Mar; 4(3):327-35. PubMed ID: 1533149
[TBL] [Abstract][Full Text] [Related]
18. Cytokine combinations for induction of antigen-specific cytolytic T lymphocytes from peripheral blood lymphocytes.
Tsujitani S; Nakashima M; Watanabe T; Kaibara N; Koprowski H; Steplewski Z
Anticancer Res; 1995; 15(3):655-60. PubMed ID: 7645938
[TBL] [Abstract][Full Text] [Related]
19. IL-2, IL-6, and IFN-gamma have distinct effects on the IL-4 plus PMA-induced proliferation of thymocyte subpopulations.
Hodgkin PD; Cupp J; Zlotnik A; Howard M
Cell Immunol; 1990 Mar; 126(1):57-68. PubMed ID: 2105854
[TBL] [Abstract][Full Text] [Related]
20. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes.
Nakashima M; Watanabe T; Koprowski H; Schuchter L; Steplewski Z
Cell Immunol; 1994 Apr; 155(1):53-61. PubMed ID: 7513262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
